BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Vascular endothelial growth factor B (VEGF-B); vascular endothelial growth factor receptor 1 (FLT1; VEGFR-1)

April 21, 2016 7:00 AM UTC

Mouse studies suggest that promoting VEGF-B and inhibiting FLT1 could help treat metabolic syndrome and obesity. In a mouse model of metabolic syndrome, systemic viral vector-mediated VEGF-B expressio...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article